Wearable-enabled screening for atrial fibrillation in high-risk patients increases diagnosis and treatment without clear benefit in clinical outcomes, supporting the hypothesis of overdiagnosis.
Does wearable-enabled screening for atrial fibrillation improve clinical outcomes in high-risk patients?
Wearable-enabled AF screening in high-risk patients increases diagnosis without clear clinical benefit, highlighting the risk of overdiagnosis.
Wearable-enabled screening for AF in high-risk patients increases diagnosis and treatment without clear benefit in clinical outcomes. These findings support the hypothesis of overdiagnosis and findings highlight the need for cautious integration of consumer technologies into primary care. Further trials with extended follow-up in low-risk populations are needed to clarify when AF detection improves outcomes versus when it leads to unnecessary medicalisation and harm.
Haase et al. (Sat,) conducted a editorial in Atrial fibrillation. Wearable-enabled screening was evaluated on Clinical outcomes. Wearable-enabled screening for atrial fibrillation in high-risk patients increases diagnosis and treatment without clear benefit in clinical outcomes, supporting the hypothesis of overdiagnosis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: